6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Tsafta ≥98.0% (HPLC) Favipiravir Matsakaicin COVID-19

6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) Matsakaici ne na Favipiravir (CAS 259793-96-9).Favipiravir sabon maganin rigakafi ne mai faɗin bakan da ke nufin RNA polymerase mai dogaro da RNA (RdRp).Favipiravir ya samo asali ne a ƙarshen 1990s ta wani kamfani wanda kamfanin Japan Fujifilm ya saya daga baya a matsayin wani ɓangare na sauyawa daga kasuwancin hoto zuwa kiwon lafiya.Bayan an gwada shi akan nau'ikan ƙwayoyin cuta, an amince da maganin a Japan a cikin 2014 don amfani da gaggawa don rigakafin mura ko kuma magance sabbin nau'ikan mura.Yayin barkewar sabon coronavirus, sakamakon binciken asibiti na Phase I da aka buga a cikin Maris 2020 ya nuna cewa maganin na iya yin tasirin hanzarta kawar da kwayar cutar don rage ci gaban sabon cutar huhu.Ana iya amfani da Favipiravir a cikin kula da marasa lafiya da COVID-19 da WHO ta ba da shawarar.Babban Mai Kula da Magunguna na Indiya (DCGI) ya share shi don amfani da "ƙantacce na gaggawa" tsakanin marasa lafiya na COVID-19.